Mosquito borne diseases affect millions of people globally each year and are a major public health issue worldwide especially in tropical and subtropical regions. Diseases such as malaria, dengue, chikungunya, yellow fever, Zika virus and others transmitted by infected female mosquitoes causes significant health issues and economic losses. With growing climatic changes enabling the spread of mosquitoes to new geographic areas, the prevalence of mosquito borne illnesses such as dengue, malaria etc. is increasing rapidly. This has driven the demand for effective monitoring, diagnostic and treatment solutions for mosquito borne diseases management.
The Mosquito Borne Disease Market is estimated to be valued at US$ 3.59 Billion in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Mosquito Borne Disease Market are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed. The major players are focusing on developing innovative diagnostic solutions for rapid detection of mosquito borne diseases.
The rising incidence of Mosquito Borne Disease Market Demand such as malaria, dengue and others has opened lucrative growth opportunities for players in the mosquito borne disease diagnostics market. With growing public awareness about vector borne illnesses, the demand for point-of-care testing and home-based diagnostic kits is increasing significantly.
Global expansion has been one of the key strategies adopted by the leading players in the mosquito borne disease diagnostics market. Companies are expanding their geographical footprint through new product launches, partnerships and acquisitions to strengthen their positions in high growth regional markets.
Market Drivers
Rising environmental factors such as increasing pollution levels, improper waste disposal and climatic changes have contributed to boost in mosquito breeding which is a major driver for mosquito borne disease market growth. Persistent initiatives by governments and non-profit organizations to create awareness about prevention and treatment of mosquito borne diseases is augmenting the market expansion. Growing global healthcare expenditure provides impetus to malaria diagnostics, vaccines and other treatments.
Market Restrain
However, lack of healthcare infrastructure and resources especially in low and middle-income nations continue to hamper effective mosquito borne disease control. Unavailability of vaccines and diagnostic alternatives along with high costs associated with new treatments in these regions also poses challenges to market growth. Issues related to data management, results interpretation and quality assurance of Point-of-Care technologies limits wider adoption in primary healthcare settings.
Segment Analysis
The mosquito borne disease market is segmented on the basis of disease type and end user. Based on disease type, the market is segmented into malaria, dengue, chikungunya, zika virus infection, Lymphatic filariasis, Japanese encephalitis and others. The malaria segment dominates the market and is expected to continue its dominance over the forecast period owing to the high prevalence and mortality rate associated with malaria especially in Asia Pacific and Africa regions. Malaria causes over 200 million cases and 400,000 deaths annually worldwide according to WHO. Based on end user, the market is segmented into hospitals, clinics and others. The hospitals segment dominates the market due to availability of advanced healthcare infrastructure and treatment facilities along with skilled healthcare professionals for effectively diagnosing and treating mosquito borne diseases.
Global Analysis
Regionally, the Asia Pacific region holds the largest share in the mosquito borne disease market and is expected to be the fastest growing region during the forecast period. Factors such as presence of endemic countries for mosquito borne diseases especially malaria and dengue, changing environmental conditions favoring mosquito breeding, increasing healthcare expenditure and growing awareness regarding these diseases drive the market in this region. India, China, Indonesia, Bangladesh, Philippines and Malaysia are major countries contributing to the Asia Pacific market. North America is expected to grow at a significant rate owing to increasing trade opportunities with endemic regions and growth in healthcare sector of the region.
Get more insights on Mosquito Borne Disease Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
